Title | Lipid mixtures containing a very high proportion of saturated fatty acids only modestly impair insulin signaling in cultured muscle cells. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Newsom, SA, Everett, AC, Park, S, Van Pelt, DW, Hinko, A, Horowitz, JF |
Journal | PLoS One |
Volume | 10 |
Issue | 3 |
Pagination | e0120871 |
Date Published | 03/2015 |
ISSN | 1932-6203 |
Keywords | Animals, Cell Line, Cells, Cultured, Fatty Acids, Humans, Insulin, Lipid Metabolism, Mice, Muscle Fibers, Skeletal, Signal Transduction |
Abstract | In vitro examinations of the effect of saturated fatty acids on skeletal muscle insulin action often use only one or two different fatty acid species, which does not resemble the human plasma fatty acid profile. We compared graded concentrations (0.1-0.8 mM) of 3 different lipid mixtures: 1) a physiologic fatty acid mixture (NORM; 40% saturated fatty acids), 2) a physiologic mixture high in saturated fatty acids (HSFA; 60% saturated fatty acids), and 3) 100% palmitate (PALM) on insulin signaling and fatty acid partitioning into triacylglycerol (TAG) and diacylglycerol (DAG) in cultured muscle cells. As expected, PALM readily impaired insulin-stimulated pAktThr308/Akt and markedly increased intracellular DAG content. In contrast, the fatty acid mixtures only modestly impaired insulin-stimulated pAktThr308M/Akt, and we found no differences between NORM and HSFA. Importantly, NORM and HSFA did not increase DAG content, but instead dose-dependently increased TAG accumulation. Therefore, the robust impairment in insulin signaling found with palmitate exposure was attenuated with physiologic mixtures of fatty acids, even with a very high proportion of saturated fatty acids. This may be explained in part by selective partitioning of fatty acids into neutral lipid (i.e., TAG) when muscle cells were exposed to physiologic lipid mixtures. |
DOI | 10.1371/journal.pone.0120871 |
Alternate Journal | PLoS ONE |
PubMed ID | 25793412 |
PubMed Central ID | PMC4368748 |
Grant List | P30 DK020572 / DK / NIDDK NIH HHS / United States DK077966 / DK / NIDDK NIH HHS / United States |